Withaferin A decreases glycolytic reprogramming in breast cancer
Withaferin A decreases glycolytic reprogramming in breast cancer
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Reprogrammed glucose metabolism is considered as the hallmark of cancer with therapeutic implications. Phytocompounds have potential to inhibit cancer metabolism. Here, we tested the ability of Withaferin A (WA), a withanolide derived from
Withania somnifera
, in modulating cancer metabolism. The assessed effect of WA on aerobic glycolysis in...
Alternative Titles
Full title
Withaferin A decreases glycolytic reprogramming in breast cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_31945fdfdfaa47d9a66d719add4b8381
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_31945fdfdfaa47d9a66d719add4b8381
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-72221-5
